{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "frameshift due to deletion followed by insertion at position 899",
      "alt": "deletion followed by insertion resulting in premature truncation of the protein",
      "position": "Exon 21, position 899"
    },
    "variant_string_id": "EGFR del899fsinsN"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The study investigates the effect of EGFR mutations on kinase activity. The del899fsinsN mutation causes a frameshift leading to premature truncation of the protein, which is expected to disrupt receptor function.",
      "judgment": "Yes",
      "reasoning": "The paper clearly defines the disease mechanism as the disruption of EGFR kinase activity due to structural changes caused by the del899fsinsN mutation."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The study uses an enzyme activity assay to measure EGFR kinase activity. This is a standard approach for assessing functional changes in EGFR mutations.",
      "judgment": "Yes",
      "reasoning": "Enzyme activity assays are widely accepted for evaluating the functional consequences of EGFR mutations, making them highly applicable to the defined disease mechanism."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "The assay includes basic controls (wild-type and known activating mutations) but does not explicitly mention replicates. The study cites prior validation of this assay in other EGFR mutants.",
      "judgment": "Yes",
      "reasoning": "While the paper does not provide explicit details on replicates, it uses a widely accepted assay and cites prior validation. Therefore, the assay is considered valid."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "The study does not provide statistical analyses or OddsPath values for this variant.",
      "judgment": "No",
      "reasoning": "Since no statistical analyses are provided, the functional evidence strength is assigned based on prior validation and basic controls."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_supporting"
  },
  "overall_conclusion": "The enzyme activity assay demonstrates reduced kinase activity due to the del899fsinsN mutation, supporting its classification as pathogenic. The use of basic controls and prior validation supports this conclusion."
}